PhD Scholarships for the PhD Program in Biomedical Research, University of Cambridge & MedImmune, UK (2015)

The University of Cambridge and MedImmune are delighted to launch a collaborative PhD programme in Biomedical Research, commencing in October 2015. This innovative 4 year programme will focus on topical areas of biomedical research falling within the scope of interest of both the University of Cambridge and MedImmune. MedImmune, the global biologics unit of AstraZeneca, is focused on the areas of cardiovascular and metabolic disease, infection, respiratory and inflammatory diseases, oncology and neuroscience. This unique programme provides the opportunity to work at the interface of academia and industry. The programme aims to promote pre-clinical research, provide access to innovative translational research and to strengthen understanding of disease.

The PhD programme is based within the Departments of the School of Clinical Medicine and the School of the Biological Sciences in collaboration with industrial partner, MedImmune, also based in Cambridge.

The main educational aims of the programme are:
- to give students with relevant biological science experience at Bachelors or Masters degree level the opportunity to carry out focussed research training within their area of research interest.
- to give students the opportunity to carry out their research training, obtaining and developing skills and relevant expertise, in both an academic and industrial setting with active support from dedicated supervisors in both settings.

PhD students will have 4 years from matriculation to complete their PhDs. The programme will consist of a 3 year studentship with 4 years of funding available. Submission of a PhD thesis will be required to by the end of Year 4. Up to six students will be enrolled per year with the intention that all students will begin in October of a given year.

Further details:
http://cato.medschl.cam.ac.uk